Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bioavailability and generic prescribing.

J S Mindel

    Survey of Ophthalmology
    |November 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Bioavailability issues in ophthalmic topical medications are less understood than oral drugs. Addressing factors affecting absorption and employing standardized testing can ensure generic and therapeutic equivalency.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A lost contact lens and Actinomyces colonization in an asymptomatic patient.

    Archives of ophthalmology (Chicago, Ill. : 1960)·2000
    Same author

    Presumed bilateral occipital neurosarcoidosis. A case report.

    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·1998
    Same author

    Is Helicobacter pylori of interest to ophthalmologists?

    Ophthalmology·1997
    Same author

    Congenital Horner's syndrome does not alter Lisch nodule formation.

    Annals of neurology·1994
    Same author

    Failure of controlled clinical trial data to reach the literature.

    Clinical pharmacology and therapeutics·1992
    Same author

    Sports pharmacology.

    Clinical pharmacology and therapeutics·1991
    Same journal

    Trends in pediatric uveitis: A systematic review and meta-epidemiological investigation of geographic, economic, and climate factors.

    Survey of ophthalmology·2026
    Same journal

    Efficacy and safety of different intraocular therapies for non-infectious uveitis: A network meta-analysis.

    Survey of ophthalmology·2026
    Same journal

    Macular telangiectasia masqueraders.

    Survey of ophthalmology·2026
    Same journal

    Utilization of anterior segment optical coherence tomography in childhood glaucoma: A systematic review.

    Survey of ophthalmology·2026
    Same journal

    Peripapillary pachychoroid syndrome: Clinical and imaging features, diagnostic differentiation and therapeutic strategies.

    Survey of ophthalmology·2026
    Same journal

    Prognostic factors and postoperative outcomes in pediatric cataract patients: A systematic review and meta-analysis.

    Survey of ophthalmology·2026
    See all related articles

    Area of Science:

    • Ophthalmology
    • Pharmaceutical Sciences
    • Drug Delivery

    Background:

    • Oral drug bioinequivalence is well-documented, but bioavailability challenges with topical ophthalmic medications are less understood.
    • Factors influencing drug absorption from ophthalmic solutions include pH, partition coefficient, container impurities, and contact time.
    • Therapeutic failure in ophthalmology may stem from overlooked bioavailability problems.

    Purpose of the Study:

    • To explore bioavailability issues specific to topical ophthalmic drug products.
    • To identify factors affecting drug absorption in ophthalmic formulations.
    • To examine perspectives on bioinequivalence and generic prescribing across stakeholders.

    Main Methods:

    • Review of factors influencing drug absorption from ophthalmic solutions.

    Related Experiment Videos

  • Discussion of clinical cases where bioavailability may cause therapeutic failure.
  • Examination of industry, regulatory, and professional viewpoints on drug equivalency.
  • Consideration of in vivo and in vitro drug testing methodologies.
  • Emphasis on uniform manufacturing and storage conditions.

    • Main Results:

    • Several factors can significantly alter drug absorption from ophthalmic solutions.
    • Bioavailability problems are a potential cause of therapeutic failure in ophthalmic treatments.
    • Diverse stakeholder attitudes exist regarding bioinequivalence and generic ophthalmic drugs.
    • Standardized testing and manufacturing can help identify and mitigate bioavailability issues.

    Conclusions:

    • A comprehensive approach combining various testing techniques and quality control measures is needed.
    • Establishing "generic equivalency" and "therapeutic equivalency" as synonymous requires a rational, evidence-based program.
    • Further research and standardization are crucial for ensuring the efficacy of topical ophthalmic medications.